| Literature DB >> 32887600 |
R D Herbert1,2, J L Taylor3,4, S R Lord3,5, S C Gandevia3,5.
Abstract
BACKGROUND: The population prevalence of many diseases is known. However, little is known of the population prevalence of motor impairments.Entities:
Keywords: Balance; Contracture; Coordination; Fatigue; Motor impairment; Weakness
Mesh:
Year: 2020 PMID: 32887600 PMCID: PMC7650517 DOI: 10.1186/s12889-020-09443-5
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Estimated prevalence (%) of difficulty using hands, arms or legs, by age and sex
| Age | Men ( | Women ( | All ( |
|---|---|---|---|
| 55–64 ( | 30.9 (28.9 to 33) | 35.8 (34.1 to 37.5) | 33.4 (32.1 to 34.7) |
| 65–74 ( | 32.7 (31 to 34.4) | 37.1 (35.6 to 38.6) | 34.9 (33.8 to 36.1) |
| 75–84 ( | 36.5 (33.8 to 39.2) | 45.1 (42.6 to 47.6) | 41.1 (39.3 to 43) |
| 85+ ( | 52.1 (47.6 to 56.7) | 59.6 (55.1 to 63.9) | 56.8 (53.6 to 60) |
| Total (55+) ( | 33.7 (32.5 to 34.9) | 40.1 (39.1 to 41.2) | 37.1 (36.3 to 37.9) |
| 55–64 ( | 9.5 (8.3 to 10.9) | 14.2 (13 to 15.5) | 11.8 (11 to 12.7) |
| 65–74 ( | 10 (8.9 to 11.1) | 14.4 (13.3 to 15.5) | 12.1 (11.4 to 12.9) |
| 75–84 ( | 10.3 (8.7 to 12.2) | 16.8 (15 to 18.7) | 13.3 (12.1 to 14.6) |
| 85+ ( | 17.5 (14.3 to 21.2) | 25.2 (21.5 to 29.4) | 20.3 (17.8 to 23.1) |
| Total (55+) ( | 10.6 (9.8 to 11.4) | 15.3 (14.6 to 16.1) | 12.8 (12.3 to 13.4) |
| 55–64 ( | 8.2 (7.1 to 9.4) | 9.2 (8.2 to 10.2) | 8.7 (7.9 to 9.5) |
| 65–74 ( | 7.8 (6.9 to 8.8) | 9.3 (8.4 to 10.3) | 8.6 (7.9 to 9.3) |
| 75–84 ( | 9 (7.4 to 10.8) | 11.9 (10.3 to 13.6) | 10.3 (9.2 to 11.6) |
| 85+ ( | 13.2 (10.4 to 16.7) | 19.1 (15.7 to 23) | 15.3 (13.1 to 17.9) |
| Total (55+) ( | 8.7 (8 to 9.4) | 10.3 (9.6 to 10.9) | 9.4 (9 to 9.9) |
| 55–64 ( | 14.5 (13 to 16.1) | 15.5 (14.2 to 16.8) | 15 (14 to 16) |
| 65–74 ( | 16.1 (14.8 to 17.5) | 17.7 (16.5 to 18.9) | 16.9 (16 to 17.8) |
| 75–84 ( | 19.8 (17.6 to 22.2) | 26.4 (24.2 to 28.7) | 22.8 (21.2 to 24.5) |
| 85+ ( | 32.3 (28.2 to 36.6) | 34.8 (30.6 to 39.2) | 33.2 (30.2 to 36.4) |
| Total (55+) ( | 17.7 (16.7 to 18.7) | 19.2 (18.4 to 20.1) | 18.4 (17.8 to 19.1) |
Prevalence is given as a percentage of people in that cell. Marginal totals (Ns) are for the population (not the sample) based on Australian Bureau of Statistics data for 2018 [20]. The mean age of men and women within each age category differed by less than 0.2 years
Estimated prevalence (%) of motor impairments by age and sex
| Age | Men | Women | All |
|---|---|---|---|
| 55–64 | 7.1 (6 to 8.3) | 11.4 (10.4 to 12.6) | 9.3 (8.6 to 10.1) |
| 65–74 | 8.8 (7.8 to 9.9) | 12.3 (11.3 to 13.4) | 10.6 (9.9 to 11.3) |
| 75–84 | 11.7 (9.9 to 13.8) | 16.1 (14.3 to 18.1) | 14.1 (12.8 to 15.5) |
| 85+ | 21.2 (17.7 to 25.1) | 22.5 (19 to 26.4) | 22 (19.4 to 24.8) |
| Total (55+) | 9.3 (8.6 to 10.1) | 13.6 (12.9 to 14.4) | 11.6 (11 to 12.1) |
| 55–64 | 5.5 (4.5 to 6.6) | 6.2 (5.4 to 7) | 5.8 (5.2 to 6.5) |
| 65–74 | 6.5 (5.7 to 7.5) | 8.3 (7.5 to 9.2) | 7.4 (6.9 to 8.1) |
| 75–84 | 10.8 (9.1 to 12.7) | 11.6 (10.1 to 13.3) | 11.2 (10.1 to 12.4) |
| 85+ | 18.9 (15.6 to 22.8) | 21.6 (18.1 to 25.5) | 20.6 (18 to 23.4) |
| Total (55+) | 7.5 (6.9 to 8.2) | 9.3 (8.7 to 9.9) | 8.5 (8 to 8.9) |
| 55–64 | 7.1 (6.1 to 8.3) | 6.3 (5.5 to 7.3) | 6.7 (6 to 7.4) |
| 65–74 | 8 (7 to 9.1) | 7.9 (7.1 to 8.8) | 8 (7.3 to 8.6) |
| 75–84 | 9.8 (8.2 to 11.7) | 10.2 (8.7 to 11.8) | 10 (8.9 to 11.3) |
| 85+ | 15.2 (12.1 to 18.9) | 12.3 (9.7 to 15.4) | 13.4 (11.3 to 15.7) |
| Total (55+) | 8.4 (7.7 to 9.1) | 8.1 (7.5 to 8.7) | 8.2 (7.8 to 8.7) |
| 55–64 | 1.7 (1.2 to 2.4) | 2.4 (1.9 to 2.9) | 2.1 (1.7 to 2.5) |
| 65–74 | 2.3 (1.8 to 2.8) | 3.8 (3.2 to 4.5) | 3 (2.7 to 3.5) |
| 75–84 | 5.4 (4.3 to 6.8) | 7.5 (6.3 to 8.9) | 6.5 (5.7 to 7.5) |
| 85+ | 13.7 (10.9 to 17.1) | 16.7 (13.6 to 20.3) | 15.6 (13.3 to 18.1) |
| Total (55+) | 3.2 (2.8 to 3.7) | 5.1 (4.6 to 5.6) | 4.2 (3.9 to 4.6) |
| 55–64 | 2.5 (1.9 to 3.3) | 2.3 (1.8 to 2.8) | 2.4 (2 to 2.8) |
| 65–74 | 2.8 (2.3 to 3.5) | 3.4 (2.8 to 4) | 3.1 (2.7 to 3.6) |
| 75–84 | 3.9 (3 to 5) | 5.6 (4.5 to 6.9) | 4.8 (4.1 to 5.7) |
| 85+ | 9.8 (7.5 to 12.7) | 7.9 (5.8 to 10.6) | 8.6 (7 to 10.5) |
| Total (55+) | 3.3 (2.9 to 3.7) | 3.7 (3.3 to 4.2) | 3.5 (3.2 to 3.8) |
| 55–64 | 13.7 (12.3 to 15.3) | 17.6 (16.3 to 19) | 15.7 (14.7 to 16.7) |
| 65–74 | 16.5 (15.2 to 17.9) | 21.1 (19.9 to 22.5) | 18.8 (17.9 to 19.8) |
| 75–84 | 23.4 (21.1 to 25.8) | 28.5 (26.3 to 30.8) | 26.1 (24.5 to 27.8) |
| 85+ | 37.9 (33.6 to 42.4) | 44 (39.7 to 48.5) | 41.8 (38.6 to 45) |
| Total (55+) | 17.7 (16.8 to 18.7) | 23.2 (22.3 to 24.1) | 20.6 (19.9 to 21.3) |
Prevalence is given as a percentage of people in that cell